Arkolith/Insider Trading/SBTX/Form 4

Root Jonathan D

DirectorSilverback Therapeutics, Inc. (SBTX) · full profile →Form 4 · filed Mar 18, 2022
Net Buying
Open-Market Buys
$36K
Open-Market Sells
$0
Net Open-Market Flow
$36K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 15, 2021Buy(P)2K$8.85$18K2K
Mar 3, 2021Buy(P)350$52.07$18K350

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-22-008141) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML